OPOCRIN GROUP Trademark

Trademark Overview


On Friday, November 26, 2021, a trademark application was filed for OPOCRIN GROUP with the United States Patent and Trademark Office. The USPTO has given the OPOCRIN GROUP trademark a serial number of 79331046. The federal status of this trademark filing is REGISTERED as of Tuesday, August 22, 2023. This trademark is owned by OPOCRIN S.p.A.. The OPOCRIN GROUP trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Chemical preparations for pharmaceutical or medical purposes, namely, for treating Respiratory Distress Syndrome (RDS) in premature infants, for preventing venous and arterial thrombosis and cardiovascular disease and for the treatment of iron deficiency anemia; enzymes for medical purposes

Chemicals for use in the manufacture of pharmaceuticals; active chemical ingredients for use in the manufacture of pharmaceuticals for treating Respiratory Distress Syndrome (RDS) in premature infants, for preventing venous and arterial thrombosis and cardiovascular disease and for the treatment of iron deficiency anemia
opocrin group

General Information


Serial Number79331046
Word MarkOPOCRIN GROUP
Filing DateFriday, November 26, 2021
Status700 - REGISTERED
Status DateTuesday, August 22, 2023
Registration Number7141201
Registration DateTuesday, August 22, 2023
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 6, 2023

Trademark Statements


Description of MarkThe mark consists of the wording "OPOCRIN GROUP" appearing in blue stylized text to the right of an incomplete circular design with a curved cut-out feature in orange with yellow highlights.
Goods and ServicesChemical preparations for pharmaceutical or medical purposes, namely, for treating Respiratory Distress Syndrome (RDS) in premature infants, for preventing venous and arterial thrombosis and cardiovascular disease and for the treatment of iron deficiency anemia; enzymes for medical purposes
Indication of Colors claimedThe color(s) yellow, orange and blue is/are claimed as a feature of the mark.
Goods and ServicesChemicals for use in the manufacture of pharmaceuticals; active chemical ingredients for use in the manufacture of pharmaceuticals for treating Respiratory Distress Syndrome (RDS) in premature infants, for preventing venous and arterial thrombosis and cardiovascular disease and for the treatment of iron deficiency anemia
NOT AVAILABLE"GROUP"

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, January 25, 2022
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 25, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOPOCRIN S.p.A.
Party Type30 - Original Registrant
Legal Entity Type35 - NOT AVAILABLE
AddressIT

Party NameOPOCRIN S.p.A.
Party Type20 - Owner at Publication
Legal Entity Type35 - NOT AVAILABLE
AddressIT

Party NameOPOCRIN S.p.A.
Party Type10 - Original Applicant
Legal Entity Type35 - NOT AVAILABLE
AddressIT

Trademark Events


Event DateEvent Description
Thursday, January 13, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, January 24, 2022LIMITATION FROM ORIGINAL APPLICATION ENTERED
Tuesday, January 25, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, January 29, 2022APPLICATION FILING RECEIPT MAILED
Friday, April 1, 2022NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, September 7, 2022ASSIGNED TO EXAMINER
Wednesday, September 7, 2022NON-FINAL ACTION WRITTEN
Thursday, September 8, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, November 3, 2022REFUSAL PROCESSED BY MPU
Thursday, November 3, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, November 21, 2022REFUSAL PROCESSED BY IB
Tuesday, April 25, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 25, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 26, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 28, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, May 14, 2023NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, May 17, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 17, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, May 17, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Saturday, May 27, 2023NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, June 6, 2023PUBLISHED FOR OPPOSITION
Tuesday, June 6, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 6, 2023NOTIFICATION PROCESSED BY IB
Wednesday, June 14, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sunday, June 18, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Monday, July 3, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, August 22, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 22, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, November 22, 2023FINAL DISPOSITION PROCESSED
Wednesday, November 22, 2023FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, November 22, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, December 11, 2023FINAL DECISION TRANSACTION PROCESSED BY IB